A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

Author： Matsueda Kei   Harasawa Shigeru   Hongo Michio   Hiwatashi Nobuo   Sasaki Daisuke  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.43, Iss.10, 2008-01, pp. : 1202-1211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome

By  

Digestion, Vol. 77, Iss. 3-4, 2008-06 ,pp. : 225-235

Karger

Access to resources Recommend Favorite

Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: A randomized, placebo-controlled, double-blind clinical trial

By Brinkhaus Benno   Hentschel Christian   Keudell Christoph Von   Schindler Gernot   Lindner Martin   Stützer Hartmut   Kohnen Ralf   Willich Stefan   Lehmacher Walter   Hahn Eckhart G.  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 8, 2005-08 ,pp. : 936-943

Informa Healthcare

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

A Randomized, Double-Blind Placebo-Controlled Trial of Iron in Restless Legs Syndrome

By  

European Neurology, Vol. 43, Iss. 2, 2000-02 ,pp. : 70-75

Karger

Access to resources Recommend Favorite

Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial

By Kamischke A  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 596-603

Oxford University Press

Access to resources Recommend Favorite